Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Stoppa

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
The New England Journal of Medicine|July 11, 1996
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du MyélomeM Attal, J L Harousseau, A M Stoppa, et al.
Hematology and Cell Therapy|April 8, 1999
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvementF Viret, D Blaise, R Bouabdallah, et al.
Leukemia & Lymphoma|September 16, 2011
Efficacy of bendamustine in relapsed/refractory myeloma patients: results from the French compassionate use programG Damaj, F Malard, C Hulin, et al.
Leukemia|June 9, 1999
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patientsR Bouabdallah, A M Stoppa, J F Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphomaA M Stoppa, R Bouabdallah, C Chabannon, et al.
Journal of Viral Hepatitis|December 17, 2009
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancerP Borentain, P Colson, D Coso, et al.
European Cytokine Network|March 8, 2000
Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remissionD Blaise, M Attal, J Reiffers, et al.
Bone Marrow Transplantation|July 5, 2011
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costsC Faucher, A G Le Corroller Soriano, B Esterni, et al.
Leukemia & Lymphoma|November 9, 2001
Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT Study GroupE Jourdan, J Reiffers, A M Stoppa, et al.
Leukemia & Lymphoma|May 1, 1997
The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remissionD Blaise, M Attal, J L Pico, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
The New England Journal of Medicine|July 11, 1996
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du MyélomeM Attal, J L Harousseau, A M Stoppa, et al.
Hematology and Cell Therapy|April 8, 1999
Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvementF Viret, D Blaise, R Bouabdallah, et al.
Leukemia & Lymphoma|September 16, 2011
Efficacy of bendamustine in relapsed/refractory myeloma patients: results from the French compassionate use programG Damaj, F Malard, C Hulin, et al.
Leukemia|June 9, 1999
Intensive sequential chemotherapy (ISC 95) with growth factors and blood stem cell support in high-intermediate and high-risk (IPI 2 and IPI 3) aggressive non-Hodgkin's lymphoma: an oligocentric report on 42 patientsR Bouabdallah, A M Stoppa, J F Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Intensive sequential chemotherapy with repeated blood stem-cell support for untreated poor-prognosis non-Hodgkin's lymphomaA M Stoppa, R Bouabdallah, C Chabannon, et al.
Journal of Viral Hepatitis|December 17, 2009
Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancerP Borentain, P Colson, D Coso, et al.
European Cytokine Network|March 8, 2000
Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remissionD Blaise, M Attal, J Reiffers, et al.
Bone Marrow Transplantation|July 5, 2011
Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costsC Faucher, A G Le Corroller Soriano, B Esterni, et al.
Leukemia & Lymphoma|November 9, 2001
Outcome of adult patients with acute myeloid leukemia who failed to achieve complete remission after one course of induction chemotherapy: a report from the BGMT Study GroupE Jourdan, J Reiffers, A M Stoppa, et al.
Leukemia & Lymphoma|May 1, 1997
The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remissionD Blaise, M Attal, J L Pico, et al.
Pageof 14